Targeting sodium channels in cardiac arrhythmia

被引:27
作者
Remme, Carol Ann [1 ]
Wilde, Arthur A. M. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Clin & Expt Cardiol, NL-1012 WX Amsterdam, Netherlands
关键词
LONG-QT SYNDROME; MYOCARDIAL-INFARCTION; VENTRICULAR-ARRHYTHMIAS; ATRIAL-FIBRILLATION; HEART-FAILURE; RANOLAZINE; MORTALITY; PATHOPHYSIOLOGY; HETEROGENEITY; (DYS)FUNCTION;
D O I
10.1016/j.coph.2013.11.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cardiac voltage-gated sodium channels are responsible for proper electrical conduction in the heart. During acquired pathological conditions and inherited sodium channelopathies, altered sodium channel function causes conduction disturbances and ventricular arrhythmias. Although the clinical, genetic and biophysical characteristics of cardiac sodium channel disease have been extensively studied, limited progress has been made in the development of treatment strategies targeting sodium channels. Classical non-selective sodium channel blockers have only limited clinical applicability, while more selective inhibitors of the late sodium current constitute a more promising treatment option. Because of our insufficient understanding of their complexity and subcellular diversity, other specific therapeutic targets for modulating sodium channels remain elusive. The current status and future potential of targeting sodium channels in cardiac arrhythmias are discussed.
引用
收藏
页码:53 / 60
页数:8
相关论文
共 54 条
  • [41] Ranolazine Safely Decreases Ventricular and Atrial Fibrillation in Timothy Syndrome (LQT8)
    Shah, Dipak P.
    Baez-Escudero, Jose L.
    Weisberg, Ian L.
    Beshai, John F.
    Burke, Martin C.
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2012, 35 (03): : E62 - E64
  • [42] Cardiac sodium channel NaV1.5 distribution in myocytes via interacting proteins: The multiple pool model
    Shy, Diana
    Gillet, Ludovic
    Abriel, Hugues
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2013, 1833 (04): : 886 - 894
  • [43] Antiarrhythmic effects of the highly selective late sodium channel current blocker GS-458967
    Sicouri, Serge
    Belardinelli, Luiz
    Antzelevitch, Charles
    [J]. HEART RHYTHM, 2013, 10 (07) : 1036 - 1043
  • [44] Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence
    Spoladore, Roberto
    Maron, Martin S.
    D'Amato, Rossella
    Camici, Paolo G.
    Olivotto, Iacopo
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (14) : 1724 - +
  • [45] Late sodium current contributes to diastolic cell Ca2+ accumulation in chronic heart failure
    Undrovinas, Nidas A.
    Maltsev, Victor A.
    Belardinelli, Luiz
    Sabbah, Hani N.
    Undrovinas, Albertas
    [J]. JOURNAL OF PHYSIOLOGICAL SCIENCES, 2010, 60 (04) : 245 - 257
  • [46] Comparison of the effects of class I anti-arrhythmic drugs, cibenzoline, mexiletine and flecainide, on the delayed rectifier K+ current of guinea pig ventricular myocytes
    Wang, DW
    Kiyosue, T
    Sato, T
    Arita, M
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1996, 28 (05) : 893 - 903
  • [47] Wilde A., 1998, Card. Electrophysiol. Rev, V2, P136, DOI [10.1023/A:1009915413034, DOI 10.1023/A:1009915413034]
  • [48] Phenotypical Manifestations of Mutations in the Genes Encoding Subunits of the Cardiac Sodium Channel
    Wilde, Arthur A. M.
    Brugada, Ramon
    [J]. CIRCULATION RESEARCH, 2011, 108 (07) : 884 - U245
  • [49] Anti-Anginal and Anti-Ischemic Effects of Late Sodium Current Inhibition
    Wimmer, Neil J.
    Stone, Peter H.
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2013, 27 (01) : 69 - 77
  • [50] Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome
    Wu, L
    Shryock, JC
    Song, YJ
    Li, Y
    Antzelevitch, C
    Belardinelli, L
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (02) : 599 - 605